Diabetes & metabolic syndrome
-
Diabetes Metab Syndr · Nov 2020
Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients.
SARS-CoV-2 infection alters various blood parameters, which may indicate disease severity and thus help in better clinical management. ⋯ Older age, higher TLC, neutrophilia, lymphopenia, eosinopenia, high NLR and high NMR are associated with severe COVID-19. High NLR and high NMR are indicative of severe disease among diabetic patients. High NLR also indicates severe disease among hypertensive patients.
-
Diabetes Metab Syndr · Nov 2020
Meta AnalysisStatin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection.
The coronavirus disease 2019 (COVID-19) number of death cases is still increasing. One of the comorbidities associated with severe outcome and mortality of COVID-19 is dyslipidemia. Statin is one of the drugs which is most commonly used for the treatment of dyslipidemic patients. This study aims to analyze the association between statin use and in-hospital outcomes of COVID-19 infection. ⋯ Statin use did not improve in-hospital outcomes of COVID-19 infections. Patients with dyslipidemia should continue taking statin drugs despite COVID-19 infection status, given its beneficial effects on cardiovascular outcomes.
-
Diabetes Metab Syndr · Nov 2020
ReviewPsychological adaptive difficulties and their management during COVID-19 pandemic in people with diabetes mellitus.
People with diabetes have multiple psychosocial issues related to diabetes and its complications and this may be exacerbated during the COVID-19 pandemic. ⋯ People with diabetes have significant diabetes distress and psychological adaptive difficulties that is aggravated by the COVID-19 pandemic. An integrated multidisciplinary approach is needed to manage the prevailing psychological issues amongst people with diabetes during the COVID-19 pandemic.
-
Diabetes Metab Syndr · Nov 2020
Clinical characteristics of hospitalized and home isolated COVID-19 patients with type 1 diabetes.
To elucidate the clinical features of COVID-19 patients with type 1 diabetes (T1D) under hospitalization and home isolation conditions. ⋯ Majority of the COVID-19 patients with T1D recovered with conservative treatment at home. Diabetic ketoacidosis was the most common reason for hospitalization.
-
Diabetes Metab Syndr · Nov 2020
Serum salusin-β in relation to atherosclerosis and ventricular dysfunction in patients with type 2 diabetes mellitus.
Salusin-β is a newly defined biomarker that plays a role in atherogenesis and in homeostasis. The study aimed to assess serum salusin-β level in relation to atherosclerosis and ventricular dysfunction in type 2 diabetes mellitus (T2DM) patients. ⋯ Serum salusin-β may be associated with atherosclerosis and LV dysfunction in T2DM.